0,815  0,002  Antiparkinsonian, rigidity relieving
0,753  0,017  Caspase 9 stimulant
0,729  0,005  5 Hydroxytryptamine release stimulant
0,705  0,004  Muscle relaxant
0,669  0,012  Respiratory analeptic
0,646  0,004  Skeletal muscle relaxant
0,621  0,027  Antineoplastic (lung cancer)
0,590  0,004  Alpha 2 adrenoreceptor antagonist
0,588  0,005  Sigma receptor agonist
0,573  0,005  Alpha adrenoreceptor antagonist
0,570  0,009  Hypoxia-inducible factor 1 alpha inhibitor
0,571  0,016  CYP1A2 substrate
0,580  0,031  CYP3A4 substrate
0,549  0,011  Cardiodepressant
0,551  0,037  Transcription factor NF kappa B inhibitor
0,514  0,014  CYP2D6 inhibitor
0,501  0,003  Dopamine D1 antagonist
0,555  0,059  Apoptosis agonist
0,515  0,023  CYP2D6 substrate
0,519  0,033  CYP2C9 substrate
0,489  0,007  Antineoplastic (squamous cell carcinoma)
0,492  0,021  Caspase 3 stimulant
0,483  0,024  Analeptic
0,463  0,004  Dopamine agonist
0,481  0,026  Spasmolytic
0,489  0,037  Antineoplastic (colorectal cancer)
0,480  0,029  CYP2C19 inhibitor
0,482  0,036  Antineoplastic (colon cancer)
0,444  0,005  5 Hydroxytryptamine 7 antagonist
0,474  0,037  Prostate cancer treatment
0,444  0,009  5 Hydroxytryptamine antagonist
0,454  0,020  Antineoplastic (glioblastoma multiforme)
0,473  0,045  Antileukemic
0,432  0,009  Genotoxic
0,427  0,008  Antiischemic, cerebral
0,417  0,005  Alpha 2a adrenoreceptor antagonist
0,407  0,005  5 Hydroxytryptamine 1A antagonist
0,425  0,031  Antineoplastic (glioma)
0,407  0,015  Abortion inducer
0,386  0,007  5 Hydroxytryptamine 1 antagonist
0,439  0,060  Antiparkinsonian
0,406  0,029  Mutagenic
0,376  0,005  Alpha 2b adrenoreceptor antagonist
0,375  0,011  5 Hydroxytryptamine 2 antagonist
0,432  0,071  Antineoplastic (breast cancer)
0,368  0,015  Antineoplastic (carcinoma)
0,357  0,008  Neurotrophic factor enhancer
0,384  0,044  Antiischemic
0,342  0,004  Dopamine D2 agonist
0,351  0,013  Topoisomerase II inhibitor
0,364  0,029  Antimitotic
0,369  0,048  Antineoplastic (melanoma)
0,350  0,034  Antineoplastic (small cell lung cancer)
0,353  0,040  DNA damaging
0,325  0,012  Antiadrenergic
0,364  0,055  Hepatic disorders treatment
0,364  0,055  Antidepressant
0,354  0,045  UGT1A9 substrate
0,347  0,038  Antineoplastic (lymphoma)
0,388  0,082  Histamine release inhibitor
0,313  0,012  Adrenaline antagonist
0,307  0,011  Dopamine antagonist
0,301  0,011  Topoisomerase I inhibitor
0,308  0,018  Tubulin antagonist
0,291  0,012  Alpha 1 adrenoreceptor antagonist
0,302  0,024  Male reproductive disfunction treatment
0,314  0,039  Psychostimulant
0,302  0,029  Hepatoprotectant
0,307  0,039  Cyclic AMP phosphodiesterase inhibitor
0,338  0,071  Mood disorders treatment
0,295  0,030  P-glycoprotein inhibitor
0,281  0,019  Erectile dysfunction treatment
0,322  0,065  CYP3A4 inhibitor
0,260  0,004  Antineoplastic alkaloid
0,268  0,013  5 Hydroxytryptamine 2A antagonist
0,303  0,050  Antineoplastic (liver cancer)
0,338  0,084  Stroke treatment
0,271  0,023  Antiparkinsonian, tremor relieving
0,286  0,040  5 Hydroxytryptamine 1E antagonist
0,255  0,013  Dopamine D2 antagonist
0,292  0,051  Vasodilator
0,324  0,085  Vasodilator, peripheral
0,285  0,049  DNA synthesis inhibitor
0,254  0,019  LDLR expression enhancer
0,305  0,076  Antineoplastic (brain cancer)
0,272  0,044  Antineoplastic enhancer
0,299  0,073  Antineoplastic (ovarian cancer)
0,288  0,062  Antineoplastic (non-small cell lung cancer)
0,283  0,063  Antineoplastic (cervical cancer)
0,224  0,005  Dopamine D5 antagonist
0,232  0,013  Alpha 1a adrenoreceptor antagonist
0,242  0,023  Toxic, respiratory center
0,237  0,021  Carcinogenic, group 1
0,222  0,014  Alpha 2c adrenoreceptor antagonist
0,236  0,029  Acetylcholine M1 receptor antagonist
0,228  0,023  Uterine stimulant
0,294  0,092  Vasodilator, coronary
0,226  0,026  Cholinergic antagonist
0,225  0,025  Acetylcholine antagonist
0,229  0,033  Liver fibrosis treatment
0,241  0,045  Pneumotoxic
0,266  0,071  Antihypercholesterolemic
0,213  0,024  5 Hydroxytryptamine 2B antagonist
0,357  0,168  Antiinflammatory
0,336  0,152  Antineoplastic (solid tumors)
0,238  0,055  Nitric oxide antagonist
0,264  0,084  CYP2C19 substrate
0,235  0,057  Anesthetic general
0,201  0,026  Alkylator
0,198  0,025  Acetylcholine muscarinic antagonist
0,199  0,026  DNA intercalator
0,193  0,027  Antitussive
0,183  0,017  Topoisomerase II alpha inhibitor
0,194  0,029  Antiviral (Hepatitis B)
0,245  0,081  Antineoplastic (renal cancer)
0,247  0,084  Antiprotozoal (Trypanosoma)
0,175  0,013  Dopamine D3 antagonist
0,238  0,078  NOS2 expression inhibitor
0,200  0,046  Cholinergic
0,165  0,014  CDC-like kinase 3 inhibitor
0,186  0,037  Acetylcholinesterase inhibitor
0,243  0,101  Cardioprotectant
0,187  0,046  UGT2B9 substrate
0,185  0,051  Cystic fibrosis treatment
0,173  0,040  Psychosexual dysfunction treatment
0,226  0,094  Tyrosine 3 hydroxylase inhibitor
0,202  0,071  UGT1A1 substrate
0,153  0,023  Breast cancer-resistant protein inhibitor
0,187  0,058  UGT1A3 substrate
0,140  0,010  Alpha tubulin antagonist
0,178  0,049  CDC-like kinase 1 inhibitor
0,154  0,028  Antiviral (Papilloma)
0,212  0,089  Cytostatic
0,138  0,015  Restless leg syndrome treatment
0,176  0,054  Melanin inhibitor
0,248  0,128  Prostaglandin dehydrogenase inhibitor
0,220  0,101  Antioxidant
0,253  0,136  Antiprotozoal (Plasmodium)
0,184  0,068  UGT2B7 substrate
0,139  0,023  Acetylcholine nicotinic antagonist
0,198  0,082  Pyruvate kinase inhibitor
0,177  0,063  Phobic disorders treatment
0,271  0,158  Antibacterial
0,223  0,110  Antineoplastic (pancreatic cancer)
0,126  0,013  Dopamine uptake inhibitor
0,222  0,113  UGT2B4 substrate
0,262  0,156  TNF expression inhibitor
0,216  0,111  Antipsychotic
0,123  0,019  Phosphodiesterase XI inhibitor
0,123  0,019  Phosphodiesterase 11A inhibitor
0,136  0,036  Sphingosine 1-phosphate receptor 2 agonist
0,257  0,159  15-Lipoxygenase inhibitor
0,115  0,019  Beta tubulin antagonist
0,116  0,022  ATPase (Vacuolar H+) inhibitor
0,201  0,108  Tumour necrosis factor alpha release inhibitor
0,167  0,075  ATPase inhibitor
0,101  0,009  Opioid kappa receptor agonist
0,176  0,084  Platelet adhesion inhibitor
0,207  0,115  Antineoplastic (sarcoma)
0,178  0,088  Cytotoxic
0,176  0,087  UDP-glucuronosyltransferase substrate
0,091  0,005  Ryanodine receptor antagonist
0,250  0,164  Antiprotozoal
0,113  0,028  Dual specificity tyrosine-phosphorylation regulated kinase 2 inhibitor
0,130  0,050  Microtubule formation inhibitor
0,112  0,033  Phosphodiesterase 6D inhibitor
0,084  0,009  Prolactin release inhibitor
0,102  0,027  Phosphodiesterase V inhibitor
0,139  0,068  Antifungal enhancer
0,247  0,176  Antineoplastic (myeloid leukemia)
0,112  0,044  Prolactin inhibitor
0,150  0,083  Chemopreventive
0,218  0,152  ICAM1 expression inhibitor
0,086  0,021  Glutamate (mGluR7) antagonist
0,146  0,081  Antiviral (Herpes)
0,092  0,028  Neuronal nicotinic receptor antagonist
0,094  0,030  Narcotic antagonist
0,106  0,044  Calcium antagonist
0,159  0,097  Sedative
0,077  0,017  Antibiotic Glycopeptide-like
0,097  0,039  Opioid kappa receptor antagonist
0,189  0,132  Radioprotector
0,090  0,032  Phosphodiesterase 5A inhibitor
0,092  0,035  Acetylcholine M4 receptor antagonist
0,213  0,156  Antihypertensive
0,125  0,069  Antiseptic
0,074  0,019  Dopamine transporter inhibitor
0,078  0,025  Alpha 2 adrenoreceptor agonist
0,106  0,054  Estrogen receptor beta antagonist
0,083  0,032  5 Hydroxytryptamine 1B antagonist
0,223  0,173  Immunosuppressant
0,084  0,034  Antitreponemal
0,115  0,065  Estrogen antagonist
0,150  0,100  UGT2B10 substrate
0,054  0,004  Dopamine D1 agonist
0,131  0,083  Lipid peroxidase inhibitor
0,067  0,021  Opioid mu receptor agonist
0,170  0,124  Free radical scavenger
0,149  0,103  Sensitization
0,067  0,023  Nicotinic receptor alpha7 subunit antagonist
0,073  0,029  5 Hydroxytryptamine 5A antagonist
0,073  0,030  Acetylcholine M3 receptor antagonist
0,067  0,025  Opioid agonist
0,153  0,112  Antiarrhythmic
0,082  0,041  5 Hydroxytryptamine agonist
0,093  0,052  Antiviral (Hepatitis A)
0,092  0,052  Carcinogenic, group 2A
0,095  0,056  SULT1E1 substrate
0,064  0,026  5 Hydroxytryptamine 7 agonist
0,083  0,047  Nicotinic alpha4beta2 receptor antagonist
0,119  0,083  Papain-like protease (SARS coronavirus) inhibitor
0,134  0,099  Heat shock protein 70 antagonist
0,056  0,022  Factor III inhibitor
0,060  0,027  Nicotinic alpha3beta2 receptor antagonist
0,063  0,032  5 Hydroxytryptamine 5 antagonist
0,123  0,093  UGT2B15 substrate
0,161  0,132  Antiprotozoal (Leishmania)
0,148  0,118  Antineoplastic (bone cancer)
0,079  0,049  Analgesic, opioid
0,045  0,016  Vesicle monoamine transporter inhibitor
0,079  0,051  Estrogen receptor alpha antagonist
0,070  0,043  Female sexual dysfunction treatment
0,097  0,072  Expectorant
0,075  0,051  Phosphodiesterase VI inhibitor
0,188  0,165  Antineoplastic (multiple myeloma)
0,051  0,029  5 Hydroxytryptamine 1A agonist
0,063  0,042  Acetylcholine M2 receptor antagonist
0,070  0,052  Calcium channel L-type blocker
0,149  0,131  Dual specificity tyrosine-phosphorylation regulated kinase 1A inhibitor
0,099  0,083  Anesthetic local
0,051  0,035  5 Hydroxytryptamine 4 antagonist
0,088  0,073  Butyrylcholinesterase inhibitor
0,046  0,032  Phosphodiesterase 6C inhibitor
0,062  0,047  5 Hydroxytryptamine 1D antagonist
0,051  0,037  5 Hydroxytryptamine 2 agonist
0,161  0,149  VCAM1 expression inhibitor
0,051  0,040  5 Hydroxytryptamine 1B agonist
0,159  0,148  Acute neurologic disorders treatment
0,063  0,052  Alpha adrenoreceptor agonist
0,074  0,064  Xanthine oxidase substrate
0,058  0,048  5 Hydroxytryptamine uptake inhibitor
0,072  0,063  Antineoplastic antibiotic
0,109  0,100  DNA repair enzyme inhibitor
0,079  0,070  Opioid antagonist
0,058  0,049  5 Hydroxytryptamine 2A agonist
0,164  0,156  Hypoglycemic
0,024  0,016  Dopamine autoreceptor agonist
0,019  0,013  Endothelin B receptor antagonist
0,062  0,057  5 Hydroxytryptamine 1F antagonist
0,049  0,045  Postmenopausal disorders treatment
0,026  0,022  Endothelin receptor antagonist

